Literature DB >> 2686415

Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections.

C E Cox1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2686415     DOI： 10.1016/0002-9343(89)90048-x

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

1.  Sequential therapy with ofloxacin in complicated urinary tract infections: a randomized comparative study with ciprofloxacin.

Authors:  H J Peters
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

2.  Sequential antibiotic therapy: Effective cost management and patient care.

Authors:  L A Mandell; M G Bergeron; M J Gribble; P J Jewesson; D E Low; T J Marrie; L E Nicolle
Journal:  Can J Infect Dis       Date:  1995-11

3.  Intravenous or sequential ciprofloxacin therapy in hospitalised patients with a broad spectrum of infections: a post-marketing surveillance study.

Authors:  H Koch; H Landen; K Stauch
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

4.  Complicated urinary tract infection in adults.

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

5.  Effect of enrofloxacin on digoxin clearance and steady-state serum concentrations in dogs.

Authors:  M J Novotny; D H Shaw
Journal:  Can J Vet Res       Date:  1991-04       Impact factor: 1.310

Review 6.  Modes of administration of antibiotics for symptomatic severe urinary tract infections.

Authors:  A Pohl
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

7.  Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.

Authors:  Kevin M Tomera; Emmanuel A Burdmann; Oscar G Pamo Reyna; Qi Jiang; Wendy M Wimmer; Gail L Woods; Richard M Gesser
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 8.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

Review 9.  Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C P Rains; H M Bryson; D H Peters
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.